How can we discover developable antibody-based biotherapeutics?

Antibody-based biotherapeutics have emerged as a successful class of pharmaceuticals despite significant challenges and risks to their discovery and development. This review discusses the most frequently encountered hurdles in the research and development (R&D) of antibody-based biotherapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Joschka, Rajagopal, Nandhini, Gupta, Priyanka, Gupta, Pankaj, Nixon, Andrew E., Kumar, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441133/
https://www.ncbi.nlm.nih.gov/pubmed/37609373
http://dx.doi.org/10.3389/fmolb.2023.1221626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441133/
https://www.ncbi.nlm.nih.gov/pubmed/37609373
http://dx.doi.org/10.3389/fmolb.2023.1221626

Ejemplares similares